LRRC73
gene geneOn this page
Also known as dJ337H4.2
Summary
LRRC73 (leucine rich repeat containing 73, HGNC:21375) is a protein-coding gene on chromosome 6p21.1, encoding Leucine-rich repeat-containing protein 73 (Q5JTD7).
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 43 total
- MANE Select transcript:
NM_001012974
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21375 |
| Approved symbol | LRRC73 |
| Name | leucine rich repeat containing 73 |
| Location | 6p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ337H4.2 |
| Ensembl gene | ENSG00000204052 |
| Ensembl biotype | protein_coding |
| Entrez | 221424 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000372441, ENST00000899667
RefSeq mRNA: 2 — MANE Select: NM_001012974
NM_001012974, NM_001271882
CCDS: CCDS34456
Canonical transcript exons
ENST00000372441 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001457804 | 43507456 | 43507678 |
| ENSE00001457808 | 43508298 | 43508420 |
| ENSE00001457809 | 43508760 | 43508920 |
| ENSE00003421486 | 43507826 | 43507926 |
| ENSE00003978291 | 43506968 | 43507308 |
| ENSE00003978292 | 43509514 | 43510346 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 89.76.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.5392 / max 240.8794, expressed in 1031 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 73690 | 3.3143 | 883 |
| 73689 | 0.4975 | 221 |
| 73688 | 0.4829 | 200 |
| 73686 | 0.0973 | 32 |
| 73692 | 0.0567 | 37 |
| 73687 | 0.0459 | 11 |
| 73691 | 0.0446 | 22 |
Top tissues by expression
244 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 89.76 | gold quality |
| right testis | UBERON:0004534 | 89.56 | gold quality |
| testis | UBERON:0000473 | 86.72 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.59 | gold quality |
| bronchial epithelial cell | CL:0002328 | 83.56 | gold quality |
| bronchus | UBERON:0002185 | 82.53 | gold quality |
| prefrontal cortex | UBERON:0000451 | 81.31 | gold quality |
| right frontal lobe | UBERON:0002810 | 79.69 | gold quality |
| frontal cortex | UBERON:0001870 | 79.16 | gold quality |
| neocortex | UBERON:0001950 | 78.27 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 77.74 | gold quality |
| nucleus accumbens | UBERON:0001882 | 77.63 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 77.61 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.32 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 77.24 | gold quality |
| right uterine tube | UBERON:0001302 | 77.16 | gold quality |
| right adrenal gland | UBERON:0001233 | 76.68 | gold quality |
| cerebral cortex | UBERON:0000956 | 76.59 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 75.53 | gold quality |
| cortical plate | UBERON:0005343 | 75.35 | gold quality |
| left adrenal gland | UBERON:0001234 | 74.97 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 74.89 | gold quality |
| adult organism | UBERON:0007023 | 74.79 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 74.77 | gold quality |
| forebrain | UBERON:0001890 | 74.60 | gold quality |
| adrenal cortex | UBERON:0001235 | 74.40 | gold quality |
| caudate nucleus | UBERON:0001873 | 74.30 | gold quality |
| amygdala | UBERON:0001876 | 74.09 | gold quality |
| Ammon’s horn | UBERON:0001954 | 73.77 | gold quality |
| putamen | UBERON:0001874 | 73.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.54 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting LRRC73, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-22-3P | 99.93 | 68.13 | 917 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-4725-5P | 98.67 | 65.42 | 628 |
| HSA-MIR-504-5P | 98.67 | 65.40 | 631 |
| HSA-MIR-1301-3P | 98.64 | 68.27 | 1071 |
| HSA-MIR-5047 | 98.64 | 68.62 | 1035 |
| HSA-MIR-7156-3P | 98.25 | 67.66 | 859 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-558 | 97.50 | 67.16 | 977 |
| HSA-MIR-1225-3P | 97.29 | 64.60 | 876 |
| HSA-MIR-6858-3P | 96.37 | 64.41 | 771 |
| HSA-MIR-1298-3P | 94.05 | 64.84 | 620 |
| HSA-MIR-615-3P | 90.62 | 68.07 | 69 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | lrrc73 | ENSDARG00000063411 |
| mus_musculus | Lrrc73 | ENSMUSG00000071073 |
| rattus_norvegicus | Lrrc73 | ENSRNOG00000039856 |
Protein
Protein identifiers
Leucine-rich repeat-containing protein 73 — Q5JTD7 (reviewed: Q5JTD7)
All UniProt accessions (1): Q5JTD7
RefSeq proteins (2): NP_001012992, NP_001258811 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR052201 | LRR-containing_regulator | Family |
UniProt features (11 total): repeat 7, compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JTD7-F1 | 84.29 | 0.76 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 28 (showing top):
DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, MIR558, MIR22_3P, MIR7156_3P, GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_EYE_GANGLION_CELLS, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS, FXR1_TARGET_GENES, ZNF140_TARGET_GENES, TRAVAGLINI_LUNG_CILIATED_CELL, TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL, GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
318 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC73 | ANKRD13D | Q6ZTN6 | 665 |
| LRRC73 | TEPSIN | Q96N21 | 626 |
| LRRC73 | VSIG10 | Q8N0Z9 | 556 |
| LRRC73 | DOCK3 | Q8IZD9 | 510 |
| LRRC73 | NPRL2 | Q8WTW4 | 505 |
| LRRC73 | POLR3H | Q9Y535 | 468 |
| LRRC73 | FAM153B | P0C7A2 | 376 |
| LRRC73 | ELFN1 | P0C7U0 | 348 |
| LRRC73 | BBLN | Q9BUW7 | 347 |
| LRRC73 | ANGPT4 | Q9Y264 | 345 |
| LRRC73 | OR4C46 | A6NHA9 | 336 |
| LRRC73 | GDF7 | Q7Z4P5 | 334 |
| LRRC73 | NCEH1 | Q6PIU2 | 318 |
| LRRC73 | JPH3 | Q8WXH2 | 302 |
| LRRC73 | MARK2 | Q7KZI7 | 302 |
IntAct
33 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CRTC3 | YWHAH | psi-mi:“MI:0914”(association) | 0.710 |
| LRRC73 | TSHZ3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC73 | ZNF574 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC73 | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC73 | ENPP7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC73 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC73 | RPP25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC73 | LNX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC73 | GADD45GIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC73 | CTDSP1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LRRC73 | SHANK3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LRRC73 | THAP12 | psi-mi:“MI:0914”(association) | 0.350 |
| OR10A4 | LRRC73 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRC73 | SLC27A2 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRC73 | DNAJC13 | psi-mi:“MI:0914”(association) | 0.350 |
| TSHZ3 | LRRC73 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF574 | LRRC73 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GADD45GIP1 | LRRC73 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LNX1 | LRRC73 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NTAQ1 | LRRC73 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ENPP7 | LRRC73 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PICK1 | LRRC73 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RPP25 | LRRC73 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (34): LRRC73 (Two-hybrid), LRRC73 (Two-hybrid), LRRC73 (Two-hybrid), LRRC73 (Two-hybrid), LRRC73 (Two-hybrid), LRRC73 (Two-hybrid), LRRC73 (Two-hybrid), LRRC73 (Two-hybrid), LRRC73 (Affinity Capture-MS), LRRC73 (Affinity Capture-MS), LRRC73 (Two-hybrid), LRRC73 (Two-hybrid), TBC1D5 (Affinity Capture-MS), CYHR1 (Affinity Capture-MS), VPS26A (Affinity Capture-MS)
ESM2 similar proteins: A2VDH3, A5A779, A6NIK2, B5X441, D3ZUM2, D4ABB4, E1BNS0, E2RKN7, E6ZHJ8, E9Q7T7, G1T469, I3L5V6, O75325, Q08602, Q08DG4, Q13641, Q3UGP9, Q4R588, Q4R8Y9, Q50LG9, Q53B87, Q53B88, Q587K4, Q5EA80, Q5EBP3, Q5JTD7, Q5NVK5, Q5PQP9, Q5PQV5, Q5VT99, Q6E804, Q6NUI6, Q6NW95, Q6PDS3, Q6SZW1, Q8CIG9, Q8K3Z0, Q8VHS5, Q8WXI3, Q91W61
Diamond homologs: Q587K4, Q5JTD7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
819 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:43507455:CCG:C | donor_gain | 1.0000 |
| 6:43507551:T:TA | donor_gain | 1.0000 |
| 6:43507674:AGGGT:A | acceptor_gain | 1.0000 |
| 6:43507675:GGGT:G | acceptor_gain | 1.0000 |
| 6:43507676:GGT:G | acceptor_gain | 1.0000 |
| 6:43507677:GT:G | acceptor_gain | 1.0000 |
| 6:43507678:TCT:T | acceptor_loss | 1.0000 |
| 6:43507679:C:CC | acceptor_gain | 1.0000 |
| 6:43507684:G:C | acceptor_gain | 1.0000 |
| 6:43507684:G:GC | acceptor_gain | 1.0000 |
| 6:43507694:A:AC | acceptor_gain | 1.0000 |
| 6:43507694:A:C | acceptor_gain | 1.0000 |
| 6:43507696:A:AC | acceptor_gain | 1.0000 |
| 6:43507696:A:C | acceptor_gain | 1.0000 |
| 6:43507821:C:A | donor_gain | 1.0000 |
| 6:43508432:C:CT | acceptor_gain | 1.0000 |
| 6:43508755:CTCA:C | donor_loss | 1.0000 |
| 6:43508756:TCACC:T | donor_loss | 1.0000 |
| 6:43508757:CACCA:C | donor_loss | 1.0000 |
| 6:43508758:A:AC | donor_gain | 1.0000 |
| 6:43508758:A:AG | donor_loss | 1.0000 |
| 6:43508759:C:CC | donor_gain | 1.0000 |
| 6:43508759:CCAG:C | donor_gain | 1.0000 |
| 6:43508759:CCAGA:C | donor_gain | 1.0000 |
| 6:43508916:GCAGG:G | acceptor_gain | 1.0000 |
| 6:43508917:CAGG:C | acceptor_gain | 1.0000 |
| 6:43508917:CAGGC:C | acceptor_gain | 1.0000 |
| 6:43508918:AGG:A | acceptor_gain | 1.0000 |
| 6:43508919:GG:G | acceptor_gain | 1.0000 |
| 6:43508920:GC:G | acceptor_loss | 1.0000 |
AlphaMissense
2028 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:43507616:G:C | N240K | 1.000 |
| 6:43507616:G:T | N240K | 1.000 |
| 6:43507830:G:T | A218D | 1.000 |
| 6:43508305:G:C | N183K | 1.000 |
| 6:43508305:G:T | N183K | 1.000 |
| 6:43508312:T:A | D181V | 1.000 |
| 6:43508315:A:G | L180P | 1.000 |
| 6:43508321:A:G | L178P | 1.000 |
| 6:43508370:A:G | W162R | 1.000 |
| 6:43508370:A:T | W162R | 1.000 |
| 6:43508392:G:C | N154K | 1.000 |
| 6:43508392:G:T | N154K | 1.000 |
| 6:43508408:A:G | L149P | 1.000 |
| 6:43508831:C:A | G121V | 1.000 |
| 6:43508832:C:A | G121W | 1.000 |
| 6:43509604:A:G | L61P | 1.000 |
| 6:43507587:A:C | I250S | 0.999 |
| 6:43507587:A:G | I250T | 0.999 |
| 6:43507587:A:T | I250N | 0.999 |
| 6:43507617:T:A | N240I | 0.999 |
| 6:43507626:A:G | L237S | 0.999 |
| 6:43507632:A:G | L235P | 0.999 |
| 6:43507674:A:G | L221P | 0.999 |
| 6:43507860:A:G | L208S | 0.999 |
| 6:43507866:A:G | L206P | 0.999 |
| 6:43507883:A:C | S200R | 0.999 |
| 6:43507883:A:T | S200R | 0.999 |
| 6:43507885:T:G | S200R | 0.999 |
| 6:43507890:G:T | A198D | 0.999 |
| 6:43507896:G:T | A196D | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000546252 (6:43509780 C>A,T), RS1001165297 (6:43510432 G>C,T), RS1002296891 (6:43506731 C>CA), RS1004994320 (6:43512065 G>A), RS1005557145 (6:43509279 G>A,C), RS1005702317 (6:43511326 G>A), RS1005964605 (6:43507475 G>A), RS1006600884 (6:43506953 C>T), RS1007304669 (6:43511560 C>T), RS1007737974 (6:43508087 G>T), RS1008002742 (6:43510922 T>A,C), RS1008409957 (6:43510750 A>T), RS1009038693 (6:43508935 G>C,T), RS1009582627 (6:43510991 C>T), RS1009798995 (6:43511193 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005956_58 | Waist-to-hip ratio adjusted for BMI | 7.000000e-26 |
| GCST005957_1 | Waist-to-hip ratio adjusted for BMI (age <50) | 2.000000e-14 |
| GCST005958_2 | Waist-to-hip ratio adjusted for BMI (age >50) | 2.000000e-19 |
| GCST005962_2 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 3.000000e-31 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| Valproic Acid | increases methylation, affects expression | 2 |
| Aflatoxin B1 | increases expression | 2 |
| bisphenol A | increases methylation, affects cotreatment | 1 |
| sulforaphane | decreases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| N-Nitrosopyrrolidine | increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Triclosan | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.